Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course

NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury

(2012) Marie T. Fischer et al.   BRAIN

The role of mitochondria in axonal degeneration and tissue repair in MS

(2012) J van Horssen et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

(2011) Ralf A. Linker et al.   BRAIN

Oxidative damage in multiple sclerosis lesions

(2011) L. Haider et al.   BRAIN

Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?

(2011) Alberto Gajofatto et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity

(2011) David Bates et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Biomarkers of disease activity in multiple sclerosis

(2011) Jerome J. Graber et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis

(2011) E Sbardella et al.   Multiple Sclerosis Journal

Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

(2011) M Cossburn et al.   Multiple Sclerosis Journal

The Level of Isoprostanes as a Non-invasive Marker for in vivo Lipid Peroxidation in Secondary Progressive Multiple Sclerosis

(2011) Elżbieta Miller et al.   NEUROCHEMICAL RESEARCH

T2 lesions and rate of progression of disability in multiple sclerosis

(2010) J. P. Mostert et al.   EUROPEAN JOURNAL OF NEUROLOGY

Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis

(2010) C. Lukas et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

(2010) Johannes Brettschneider et al.   PLoS One

Gray- and White-Matter Changes 1 Year after First Clinical Episode of Multiple Sclerosis: MR Imaging

(2010) Eytan Raz et al.   RADIOLOGY

Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis

(2009) Dana Horakova et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity

(2008) R.E. Gonsette   JOURNAL OF THE NEUROLOGICAL SCIENCES